Overall, the present study indicated that the combination of CXCL10 gene therapy and radiotherapy is an efficient strategy for growth suppression in cervical tumors, which may result from the attenuation of angiogenesis, decline in cell proliferation and induction of apoptosis. This evidence concerns the gene CXCL10 and uterine cervix neoplasm.